Results 71 to 80 of about 62,013 (267)

543. Sex Differences in Clinical Presentation and Outcomes of Adults Hospitalized with COVID-19 Pneumonia After Administration of Infliximab, Abatacept or Cenicriviroc: Subgroup Analysis from the ACTIV-1 Master Protocol [PDF]

open access: gold, 2023
Adriana M. Rauseo   +8 more
openalex   +1 more source

Adequate vitamin D is associated with favorable disease outcome in children with inflammatory bowel disease receiving anti‐tumor necrosis factor alpha therapy

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Deficiency of serum 25‐hydroxyvitamin D [25(OH)D] was associated with decreased short‐term response to anti‐tumor necrosis factor‐alpha (TNF‐α) agents in adults with inflammatory bowel disease (IBD). The aim of this study was to evaluate the association between serum 25(OH)D levels and the outcome of children with IBD undergoing ...
Adi Anafy   +6 more
wiley   +1 more source

Risk factors for early postoperative complications after minimally invasive surgery in pediatric ulcerative colitis

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective To report a single‐center experience with a multidisciplinary minimally invasive surgical approach for pediatric ulcerative colitis (UC) and identify risk factors for early postoperative complications (EPC). Methods A retrospective analysis was conducted on UC patients followed at the Gastroenterology Unit of Meyer Children's ...
Martina Di Benedetto   +10 more
wiley   +1 more source

Outcomes of a National Cohort of Children with Acute Severe Ulcerative Colitis

open access: yesFrontiers in Pediatrics, 2018
AimAll Irish children with ulcerative colitis (UC) attend the National Centre for Paediatric Gastroenterology at Our Lady’s Children’s Hospital, Crumlin. The aim of this study was to determine the outcomes of children with acute severe ulcerative colitis
Abisoye O. Akintimehin   +7 more
doaj   +1 more source

A case of autoimmune hepatitis in a patient with inflammatory bowel disease and significant lymphadenopathy in the porta hepatis

open access: yesJPGN Reports, EarlyView.
Abstract The diagnosis of autoimmune hepatitis (AIH) is supported by the presence of elevated transaminases, hypergammaglobulinemia, liver biopsy consistent with AIH, and the presence of AIH autoantibodies. In this case presentation, we highlight the challenges associated with diagnosing AIH in a patient with inflammatory bowel disease (IBD) who ...
Benjamin J. Malamet   +5 more
wiley   +1 more source

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease [PDF]

open access: bronze, 2004
Édouard Louis   +10 more
openalex   +1 more source

Expect the unexpected: A case of penetrating Crohn's disease complicated by foreign body ingestion

open access: yesJPGN Reports, EarlyView.
Abstract A 17‐year‐old nonverbal male with autism spectrum disorder (ASD) presented with abdominal pain, diarrhea, and weight loss. Initial workup revealed penetrating Crohn's disease (CD) with an ileosigmoid fistula and abscess. After initial improvement with antibiotics, enteral nutrition (EN), and infliximab (IFX), he developed recurrent abdominal ...
Meredith R. Kline   +2 more
wiley   +1 more source

Long term treatment with infliximab in pediatric Vogt-Koyanagi-Harada disease

open access: yesAmerican Journal of Ophthalmology Case Reports, 2018
Purpose: To report a case of pediatric Vogt-Koyanagi-Harada (VKH) successfully treated with infliximab and methotrexate for ten years. Observations: A 9-year-old Hispanic girl with VKH disease, was successfully treated with oral methotrexate 15 mg/week ...
Gustavo A. Budmann   +2 more
doaj   +1 more source

Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease [PDF]

open access: bronze, 2013
Stéphane Paul   +8 more
openalex   +1 more source

Perioperative utilization of JAK inhibitors in Perianal Fistulizing Crohn's disease

open access: yesJPGN Reports, EarlyView.
Abstract With the recent approval of small molecule drugs such as upadacitinib in adult inflammatory bowel disease (IBD), their utilization is becoming more common; however, there is limited data on perioperative risks or optimal timing of cessation and resumption to mitigate flares. Current recommendations suggest holding these medications for 14 days
Alexander Lyons   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy